Leukemia Research Reports

eISSN: 2213-0489
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

2
Time to Publish
time-to-publish View Chart
2  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    Elsevier
  • Language
    English
  • Article Processing Charges
    USD 2580
  • Publication Time
    23
  • Editorial Review Process
    Peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 66%
4-6 26%
7-9 6%
>9 2%

Topics Covered

Central nervous system
Trisomy
Unusual case
Myeloid sarcoma
Acute leukemia
Intravascular lymphoma
Obstructive jaundice
Mixed phenotype acute leukemia
Splanchnic vein thrombosis
Hematopoietic stem cell transplantation
Atypical chronic myeloid leukemia
Ibrutinib
Decitabine
Salvage therapy
FAVORABLE RESPONSE
Minimal residual disease
Total body
Lenalidomide
Essential thrombocythemia
B-cell acute lymphoblastic leukemia

Recently Published Papers

Year-wise Publication

FAQs

Who is the publisher of Leukemia Research Reports? Faqs

The publisher of Leukemia Research Reports is Elsevier.

How can I view the journal metrics of Leukemia Research Reports on editage? Faqs

For the Leukemia Research Reports metrics, please refer to the section above on the page.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Central nervous system, Trisomy, Unusual case, Myeloid sarcoma, Acute leukemia, Intravascular lymphoma, Obstructive jaundice, Mixed phenotype acute leukemia, Splanchnic vein thrombosis, Hematopoietic stem cell transplantation, Atypical chronic myeloid leukemia, Ibrutinib, Decitabine, Salvage therapy, FAVORABLE RESPONSE, Minimal residual disease, Total body, Lenalidomide, Essential thrombocythemia, B-cell acute lymphoblastic leukemia.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.